🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study investigates the efficacy of topical roflumilast foam in patient...
Status
Not Yet Recruiting
Location
Harrison Dermatology
Start Date
2026-08-10
Trial ID
NCT07689188
Treatments Being Tested
This study will assess the safety and efficacy of Roflumilast foam 0.3% (ZO...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Bengbu Medical University
Start Date
2026-08-24
Trial ID
NCT07683806
Treatments Being Tested
This was a parallel group, double blind, vehicle-controlled study assessed ...
Status
Completed
Location
Arcutis Biotherapeutics Clinical Site 19
Start Date
2019-12-04
Trial ID
NCT04091646
Treatments Being Tested
An open-label single center, proof of concept study evaluating the efficacy...
Status
Recruiting
Location
Derm Texas
Start Date
2025-08-01
Trial ID
NCT07105254
Treatments Being Tested
This phase 3, double-blind, vehicle-controlled study assessed the safety an...
Status
Completed
Location
Arcutis Biotherapeutics Clinical Site 01
Start Date
2021-07-08
Trial ID
NCT04973228
Treatments Being Tested
This is a phase 2a, open label study. As psoriasis and Hidradenitis Suppur...
Status
Recruiting
Location
Lakeview Hospital
Start Date
2025-09-25
Trial ID
NCT07077902
Treatments Being Tested
This was a parallel group, double blind, vehicle-controlled study to assess...
Status
Completed
Location
Arcutis Biotherapeutics Clinical Site 01
Start Date
2021-08-24
Trial ID
NCT05028582
Treatments Being Tested
This study investigates the efficacy of topical roflumilast foam in patient...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-09-01
Trial ID
NCT07263230
Treatments Being Tested
This study will assess the safety and efficacy of ARQ-154 foam vs placebo a...
Status
Completed
Location
Arcutis Biotherapeutics Clinical Site 71
Start Date
2020-01-13
Trial ID
NCT04128007
Treatments Being Tested
To assess the safety and efficacy of QD 0.3% topical roflumilast foam in pa...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07639840
Treatments Being Tested